Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Aug 27, 2020; 12(8): 355-368
Published online Aug 27, 2020. doi: 10.4240/wjgs.v12.i8.355
Published online Aug 27, 2020. doi: 10.4240/wjgs.v12.i8.355
Figure 7 Kaplan-Meier survival analysis of overall survival and disease-free survival of Group A and Group B.
A: Overall survival rate analysis. The difference of Group A and Group B was not statistically significant (Log Rank = 0.017, P = 0.897); B: Disease-free survival (DFS rate analysis). The DFS rate of Group B was lower than that of Group A (Log Rank = 6.123, P = 0.013).
- Citation: Zhang Y, Zhang MW, Fan XX, Mao DF, Ding QH, Zhuang LH, Lv SY. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(8): 355-368
- URL: https://www.wjgnet.com/1948-9366/full/v12/i8/355.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i8.355